2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 49.966 | 48.875 | 61.574 | 68.797 | 58.299 | 55.356 | 68.655 | 71.967 | 96.584 | 114.461 |
Total Income - EUR | 50.309 | 49.509 | 61.631 | 69.214 | 58.373 | 55.378 | 68.703 | 72.286 | 96.850 | 114.584 |
Total Expenses - EUR | 49.545 | 47.980 | 58.457 | 66.143 | 57.628 | 59.525 | 64.640 | 70.570 | 91.953 | 113.422 |
Gross Profit/Loss - EUR | 764 | 1.529 | 3.174 | 3.071 | 745 | -4.147 | 4.063 | 1.716 | 4.897 | 1.162 |
Net Profit/Loss - EUR | -746 | 43 | 2.558 | 2.378 | 161 | -4.701 | 3.568 | 1.115 | 3.944 | 36 |
Employees | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Apotecamed Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 2.988 | 2.222 | 1.474 | 1.202 | 1.088 | 947 | 840 | 0 | 143 | 208 |
Current Assets | 17.176 | 19.396 | 16.390 | 21.152 | 17.429 | 18.396 | 23.394 | 27.798 | 44.503 | 44.435 |
Inventories | 7.201 | 11.764 | 11.741 | 11.449 | 9.429 | 10.050 | 12.837 | 13.508 | 25.178 | 26.610 |
Receivables | 6.922 | 6.461 | 2.599 | 8.782 | 5.181 | 7.713 | 6.706 | 7.624 | 9.091 | 11.352 |
Cash | 3.054 | 1.171 | 2.051 | 922 | 2.819 | 633 | 3.850 | 6.667 | 10.235 | 6.473 |
Shareholders Funds | -1.586 | -1.553 | 1.021 | 3.382 | 3.481 | -1.287 | 2.305 | 3.369 | 4.401 | 87 |
Social Capital | 45 | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 |
Debts | 21.750 | 23.171 | 16.844 | 18.973 | 15.126 | 20.630 | 21.928 | 24.429 | 40.290 | 44.702 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4773 - 4773" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Apotecamed Srl